Introduction
In the evolving landscape of aesthetic medicine, non-invasive body contouring has long been established as a sought-after solution for individuals seeking effective fat reduction without the risks and downtime associated with surgical procedures. Among the innovative technologies leading this transformation is the Emerald Laser, manufactured by Erchonia Corporation, a 532nm low-level laser therapy (LLLT) device that offers a predictable, painless, and efficient method for body contouring.
This article delves into the reasons why aesthetic clinics in Australia and New Zealand are increasingly adopting Emerald Laser technology, exploring its clinical efficacy, market potential, and the unique advantages it offers to both practitioners and patients.
The Growing Demand For Non-Invasive Body Contouring
Market Trends in Australia and New Zealand
The demand for non-invasive body contouring procedures has seen consistent growth since the first of the fat freezing technologies arrived just over a decade ago. Driven by increasing health consciousness and the desire for minimally invasive aesthetic solutions. In Australia, the body contouring devices market generated revenue of USD 37.4 million in 2022 and is projected to reach USD 116.4 million by 2030, growing at a compound annual growth rate (CAGR) of 15.3%1. Similarly, the Asia Pacific non-invasive fat reduction market, which includes New Zealand, is expected to grow at a CAGR of 16.57% from 2024 to 20322.
Shifting Patient Preferences
Patients are increasingly seeking aesthetic treatments that align with their busy lifestyles and health-conscious values. They prefer procedures that are:
• Non-invasive: Avoiding surgical risks and complications.
• Pain-free: Minimizing discomfort during and after the procedure.
• No downtime: Allowing immediate return to daily activities.
• Clinically proven: Backed by scientific research and regulatory approvals.
Emerald Laser meets these criteria, making it an attractive option for both patients and clinics aiming to offer cutting-edge, patient-friendly treatments.
Understanding Emerald Laser Technology
How It Works
Emerald Laser utilizes a 532nm wavelength green laser to target adipose tissue. The laser energy penetrates the skin and creates temporary pores in fat cell membranes, allowing the stored fatty acids to be released into the interstitial space. These fatty acids are then naturally metabolised and eliminated by the body’s lymphatic system3.
Advantages Over Other Technologies
Unlike older body contouring methods such as cryolipolysis or radiofrequency, which rely on extreme temperatures to destroy fat cells, Emerald Laser’s approach is non-thermal and non-destructive. This results in:
• Reduced risk of side effects: No burns, scarring, or nerve damage.
• No inflammation: Preservation of surrounding tissues.
• Comfortable experience: Patients report no pain during treatment.
• No recovery time: Immediate return to normal activities.
Clinical Evidence Supporting Emerald Laser
Efficacy in Circumferential Reduction
Multiple clinical studies have demonstrated the effectiveness of low-level laser therapy in reducing body circumference:
• A randomized, controlled study published in Lasers in Surgery and Medicine reported significant reductions in waist, hip, and thigh measurements after treatment with a 532nm laser, perceived in as little as 2 weeks with no reported side effects.
• Another study involving 689 participants found an average reduction of 3.27 inches in waist, hips, and thighs one week after a two-week treatment regimen4.
Safety Profile
Emerald Laser has been cleared by the U.S. Food and Drug Administration (FDA Number, K192544) for non-invasive fat reduction and is listed with the Therapeutic Goods Administration (TGA, ARTG 395892) in Australia, underscoring its safety and efficacy5. No adverse events have been reported in clinical trials, and patients consistently report high satisfaction rates.
Expanding Patient Demographics
Emerald Laser’s gentle and non-invasive nature makes it suitable for a wide range of patients, including those who may not be ideal candidates for other body contouring procedures, up to a BMI of 40:
• Low BMI individuals: Seeking targeted fat reduction without significant weight loss.
• High BMI individuals: Where other technologies cannot deliver results.
• Postpartum women: Looking to address stubborn fat deposits after childbirth.
• Older adults: Desiring body contouring without the risks associated with surgery.
• Wellness-focused clients: Interested in holistic approaches to body optimisation.
Business Benefits For Clinics
Revenue Growth Opportunities
Offering Emerald Laser treatments can open new revenue streams for clinics:
• No consumables: Delivers optimised return on investment
• Completely Unattended Treatments: delegate to any staff
• Add-on services: Combining with other aesthetic treatments for comprehensive care.
• Membership models: Encouraging repeat visits through subscription-based services.
Competitive Differentiation
By incorporating Emerald Laser into their service offerings, clinics can differentiate themselves in a crowded market:
• Innovative technology: Positioning as a leader in non-invasive aesthetic solutions.
• Patient satisfaction: Attracting clients seeking effective and comfortable treatments.
• Brand reputation: Building trust through the use of clinically validated technologies.
Conclusion
Emerald Laser represents a significant advancement in non-invasive body contouring, offering a safe, effective, and patient-friendly alternative to traditional fat reduction methods. For aesthetic clinics in Australia and New Zealand, adopting this technology can lead to increased patient satisfaction, expanded service offerings, and enhanced revenue opportunities.
Speak to Our Team
To learn more about adding Emerald Laser to your clinic, including clinical data, treatment protocols, and commercial support, speak to our team today.
*Note: The information provided in this article is for educational purposes only and should not be construed as medical advice
Footnotes
1 Grand View Research. Australia Body Contouring Devices Market Size & Outlook, 2030. Retrieved from
2 Market Data Forecast. Asia Pacific Non-Invasive Fat Reduction Market Size, 2032. Retrieved from
3 Erchonia Corporation. Emerald Laser for Non-Invasive Fat Loss. Retrieved from
4 Caruso-Davis MK, Guillot TS, Podichetty VK, Mashtalir N, Dhurandhar NV, Dubuisson O, Yu Y, Greenway FL. Efficacy of low-level laser therapy for body contouring and spot fat reduction. Obes Surg. 2011;21(6):722–729.
5 Therapeutic Goods Administration (TGA). Low-intensity laser fat liquefaction system (ARTG ID 395892). Retrieved from
